Compare COLB & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COLB | ICLR |
|---|---|---|
| Founded | 1993 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6B | 9.3B |
| IPO Year | 1996 | 2001 |
| Metric | COLB | ICLR |
|---|---|---|
| Price | $31.29 | $146.29 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 13 |
| Target Price | $31.46 | ★ $178.62 |
| AVG Volume (30 Days) | ★ 2.7M | 1.1M |
| Earning Date | 04-23-2026 | 05-12-2026 |
| Dividend Yield | ★ 5.08% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.66 | N/A |
| Revenue | ★ $177,000,000.00 | N/A |
| Revenue This Year | $31.52 | N/A |
| Revenue Next Year | $2.90 | N/A |
| P/E Ratio | $46.70 | ★ $12.91 |
| Revenue Growth | ★ 18.94 | N/A |
| 52 Week Low | $21.91 | $66.57 |
| 52 Week High | $32.70 | $211.00 |
| Indicator | COLB | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 66.56 | 63.32 |
| Support Level | $28.61 | $99.11 |
| Resistance Level | $32.70 | $188.03 |
| Average True Range (ATR) | 0.60 | 8.29 |
| MACD | 0.17 | 1.04 |
| Stochastic Oscillator | 94.16 | 77.73 |
Columbia Banking System Inc is a registered bank holding company whose wholly-owned banking subsidiary is Columbia State Bank. The company provides a full range of banking services to small and medium sized businesses, professionals, and individuals throughout Washington, Oregon, Idaho, and California. The company's subsidiary Columbia Trust Company is an Oregon trust company that provides agency, fiduciary, and other related trust services with offices in Washington, Oregon, and Idaho. The firm offers various products and services under Personal Banking, Business Banking, and Wealth Management divisions.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.